HDAC8 inhibitor (NatureWise Biotech)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHDAC8 inhibitor (NatureWise Biotech)
Drug Alias Namehistone deacetylase 8 inhibitor (NatureWise Biotech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 8 inhibitors
TargetsHistone deacetylase 8
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNaturewise Biotech & Medicals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNaturewise Biotech & Medicals Corp
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A